Literature DB >> 32532620

Opportunities and challenges of traditional Chinese medicine going abroad for COVID-19 treatment.

Xiao-Qing Huang1, Meng-Yun Zhou2, Yong-Ran Cheng3, Lan Ye4, Ming-Wei Wang5, Juan Chen5, Li-Jun Zhao6, Zhan-Hui Feng7.   

Abstract

Entities:  

Year:  2020        PMID: 32532620      PMCID: PMC7274975          DOI: 10.1016/j.ajem.2020.06.008

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


× No keyword cloud information.
We appreciate the work that Kai Zhang has done to highlight the treatment of COVID-19 in China via the use of Traditional Chinese Medicine (TCM) [1]. COVID-19 initially occurred in China at the end of December 2019 [2]. The Chinese government began to build many shelter hospitals in Hubei Province to treat patients with COVID-19, and medical workers from all over the country rushed to Wuhan to provide assistance [3]. Among the medical staff supporting Hubei Province, there were more than 4500 members of China's TCM system. In addition, TCM has been approved for the treatment of COVID-19 [4]. As of March 23rd, among the patients with COVID-19, 74,187 patients (about 91.5%), had been treated with TCM; of these, 61,449 people were treated in Hubei Province (Fig. 1A). Clinical efficacy data has shown that the overall effective rate of TCM treatment has reached more than 90% [5].
Fig. 1

A. The patients with COVID-19 had been treated with TCM China and Hubei Province. B. The scale of the TCM market has significantly grown.

A. The patients with COVID-19 had been treated with TCM China and Hubei Province. B. The scale of the TCM market has significantly grown. TCM is heavily involved in the fight against COVID-19, and has played an important role in the overall prevention of the disease, as well as in the treatment and rehabilitation of infected patients [6]. According to a number of US media reports, with the spread of the epidemic in the United States, the demand for TCM to treat colds and improve immunity has increased significantly. Consequently, the scale of the TCM market has grown significantly (Fig. 1B). Although TCM treatment has played an important role in this epidemic, it is also important to note that it is relatively difficult for TCM articles to be published in journals around the world. The reasons for this are believed to be as follows. First, the treatment process of TCM is individualized; not everyone's medication is exactly the same, and it is therefore difficult to evaluate the curative effect of TCM via Western medicine assessment methods. Second, there are many classifications of TCM, and the style and manner of each type of medicine are very different. Third, the origins and curative effects of TCM are different, as can be the effects of the same prescription. Fourth, Chinese doctors generally do not accept Western medical treatment processes, and the writing method of TCM practitioners is also different from that of Western medicine practitioners. Finally, TCM practitioners are trained for a long time, and foreigners have some difficulties in understanding TCM. We believe that TCM can play an important role in the prevention and treatment of COVID-19 during this epidemic. However, determining how to improve TCM on the international stage going forward remains unclear. We trust that with the joint efforts of practitioners of TCM, it will surely be highlighted by the world.

Funding

No funding was received.

Declaration of competing interest

The authors have no conflicts of interest or financial ties to disclose.
  3 in total

1.  Is traditional Chinese medicine useful in the treatment of COVID-19?

Authors:  Kai Zhang
Journal:  Am J Emerg Med       Date:  2020-03-25       Impact factor: 2.469

Review 2.  The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak.

Authors:  Hussin A Rothan; Siddappa N Byrareddy
Journal:  J Autoimmun       Date:  2020-02-26       Impact factor: 7.094

3.  Chinese medical personnel against the 2019-nCoV.

Authors:  Zhan-Hui Feng; Yong-Ran Cheng; Juan Chen; Lan Ye; Meng-Yun Zhou; Ming-Wei Wang
Journal:  J Infect       Date:  2020-02-21       Impact factor: 6.072

  3 in total
  1 in total

1.  A systematic review and meta-analysis of the efficacy and safety of western medicine routine treatment combined with Chinese herbal medicine in the treatment of COVID-19.

Authors:  Xuemei Wang; Ping Xie; Guojuan Sun; Zhumei Deng; Min Zhao; Shuting Bao; Yunxia Zhou
Journal:  Medicine (Baltimore)       Date:  2020-08-07       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.